| Maria Del Mar Franco- Velez, MD | |
|
R 1317 D Street, Turabo Gardens, Caguas, PR 00727-5932 | |
| (787) 286-8234 | |
| Not Available |
| Full Name | Maria Del Mar Franco- Velez |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | R 1317 D Street, Caguas, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386629053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 11814 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Del Mar Franco- Velez, MD R-1317 D Street, Turabo Gardens, Caguas, PR 00727-5932 Ph: (787) 286-8234 | Maria Del Mar Franco- Velez, MD R 1317 D Street, Turabo Gardens, Caguas, PR 00727-5932 Ph: (787) 286-8234 |
News Archive
The Takeda Oncology Company today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental new drug application (sNDA) based on long- term overall survival (OS) data from the landmark VISTA1 trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
An educational program for parents helps to reduce pressure on children to eat—which may reduce the child's risk of obesity, reports a study in the September Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics.
KaloBios Pharmaceuticals, Inc. today announced an agreement with Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, for the development and commercialization of KB001, an investigational new biologic for the treatment or prevention of Pseudomonas aeruginosa (Pa) infections. Sanofi Pasteur will be responsible for the development and commercialization of KB001 and initially focus on hospital indications, including the prevention of Pa pneumonias in mechanically ventilated patients.
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.
› Verified 6 days ago
Natalia L Rodriguez Vazquez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Ofc Dra Natalia L Rodriguez Vazquez Carr 189 Km 2, Parque Industrial Caguax, Caguas, PR 00725 Phone: 787-209-0050 | |
Dr. Glisette Rodriguez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1040 Calle Carite, Urb Valles Del Lago, Caguas, PR 00725 Phone: 787-747-0553 Fax: 787-747-0553 | |
Dr. Angel Manuel Velazquez-fernandez, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: O24 Ave Luis Munoz Marin, Caguas, PR 00725 Phone: 787-744-4399 | |
Dr. Maria Del Pilar Ramirez, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Hosp San Juan Bautista, Carr 172 Km 2 7th Floor, Caguas, PR 00726 Phone: 787-258-4390 Fax: 787-704-0355 | |
Dr. Blas Delgado Ortiz, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 50 Ave Munoz Marin, Suite 307, Caguas, PR 00725 Phone: 787-746-2021 Fax: 787-746-4248 | |
Dr. Maria Del Carmen Odriozola I, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: B17 Calle San Ignacio, San Pedro Estates, Caguas, PR 00725 Phone: 787-396-7018 Fax: 787-286-1812 | |
Dr. Migna Arroyo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 46 Calle Topacio, Villa Blanca, Caguas, PR 00725 Phone: 787-249-6232 |